A Case-Control Study to Add Volumetric or Clinical Mammographic Density into the Tyrer-Cuzick Breast Cancer Risk Model

• Published in: Journal of breast imaging Vol. 1; no. 2; pp. 99 - 106
• Main Authors: Brentnall, Adam R, Cohn, Wendy F, Knaus, William A, Yaffe, Martin J, Cuzick, Jack, Harvey, Jennifer A
• Format: Journal Article
• Language: English
• Published: United States Oxford University Press 01-06-2019
• Subjects: Original Research; breast cancer risk models; risk factors; early detection of cancer; breast density; breast neoplasms
• ISSN: 2631-6110; 2631-6129
• DOI: 10.1093/jbi/wbz006

Accurate breast cancer risk assessment for women attending routine screening is needed to guide screening and preventive interventions. We evaluated the accuracy of risk predictions from both visual and volumetric mammographic density combined with the Tyrer-Cuzick breast cancer risk model.
A case-control study (474 patient participants and 2243 healthy control participants) of women aged 40-79 years was performed using self-reported classical risk factors. Breast density was measured by using automated volumetric software and Breast Imaging and Reporting Data System (BI-RADS) density categories. Odds ratios (95% CI) were estimated by using logistic regression, adjusted for age, demographic factors, and 10-year risk from the Tyrer-Cuzick model, for a change from the 25
to 75
percentile of the adjusted percent density distribution in control participants (IQ-OR).
After adjustment for classical risk factors in the Tyrer-Cuzick model, age, and body mass index (BMI), BI-RADS density had an IQ-OR of 1.55 (95% CI = 1.33 to 1.80) compared with 1.40 (95% CI = 1.21 to 1.60) for volumetric percent density. Fibroglandular volume (IQ-OR = 1.28, 95% CI = 1.12 to 1.47) was a weaker predictor than was BI-RADS density (P
= 0.014) or volumetric percent density (P
= 0.065). In this setting, 4.8% of women were at high risk (8% + 10-year risk), using the Tyrer-Cuzick model without density, and 7.1% (BI-RADS) compared with 6.8% (volumetric) when combined with density.
The addition of volumetric and visual mammographic density measures to classical risk factors improves risk stratification. A combined risk could be used to guide precision medicine, through risk-adapted screening and prevention strategies.